Company Profile

WCG Clinical Holdings Inc is a United States-based company. The Company is a provider of clinical trial solutions. It is focused on providing solutions that are designed to improve clinical research. Its solutions help biopharmaceutical companies, contract research organizations, and institutions for delivery of new treatments and therapies to patients. It is organized into two segments: Ethical Review (ER) segment and Clinical Trial Solutions segment. The ER segment provides technology-enabled services that ensure clinical trials respect the rights and protect the welfare of patient participants. ER segment also provides a hosted software application to its clients. Clinical Trial Solutions (CTS) segment provides technology-enabled solutions that support the conduct of effective clinical trials, including study planning and site optimization, patient engagement, and scientific and regulatory review.

Employees

Sector

Biotechnology & Medical Research

More about the company

Delayed Nasdaq Other stock markets			5-day change	1st Jan Change
- ^USD	-.--%		-.--%	-

Nov. 12	Wcg Introduces Breakthrough Analytics to Optimize and Accelerate Clinical Trial Outcomes	CI
25-09-15	WCG Announces the Launch of WCG ClinSphere E eReview Manager	CI

Nov. 12	Wcg Introduces Breakthrough Analytics to Optimize and Accelerate Clinical Trial Outcomes	CI
25-09-15	WCG Announces the Launch of WCG ClinSphere E eReview Manager	CI
25-08-25	WCG Reduces Clinical Trial Protocol Deviation by 35-50% with the Launch of Total Training, the First Comprehensive Solution for Improved Site Readiness, Engagement, and Compliance	CI
25-05-05	EResearchTechnology, Inc. completed the acquisition of eCOA business of WCG Clinical, Inc.	CI
25-04-03	WCG Announces Research Resilience Solutions to Navigate Institutional Budget Constraints	CI
25-03-09	EResearchTechnology, Inc. entered into a definitive agreement to acquire eCOA business of WCG Clinical, Inc.	CI
25-01-27	WCG Launches ClinSphere? Total Enrollment: An All-New Participant Recruitment and Retention SaaS Solution for Clinical Trials	CI
24-08-04	WCG Clinical, Inc. acquired Educational Measures, LLC.	CI
21-10-13	WCG Clinical : GIC-backed clinical trial firm WCG withdraws U.S. IPO plans	RE
21-10-13	WCG Clinical : GIC-backed clinical trial firm WCG withdraws IPO plans	RE
21-10-13	WCG Clinical, Inc. has withdrawn its IPO in the amount of $765 million.	CI
21-07-25	WCG Clinical, Inc. acquired VeraSci for $330 million.	CI
21-07-01	WCG Clinical, Inc. has filed an IPO in the amount of $100 million.	CI

Manager	Title	Age	Since
Srivastava Sam CEO	Chief Executive Officer	-	2022-05-17
Robert VanHees PSD	President	-	-
Ian Neilson CTO	Chief Tech/Sci/R&D Officer	-	2017-12-31

Director	Title	Age	Since
John Baumer BRD	Director/Board Member	58	2018-12-31
Eugene Gorbach BRD	Director/Board Member	49	2011-12-31
Henrik Kjaer Hansen BRD	Director/Board Member	50	2019-12-31

WCG Clinical, Inc. Stock

Equities

WCGC

US92941R1095

Biotechnology & Medical Research

Latest news : WCG Clinical, Inc.

Managers and Directors: WCG Clinical, Inc.

Other Biotechnology & Medical Research

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
WCG CLINICAL, INC.	-.--%	-.--%	-	-	6.07B
LONZA GROUP AG	-1.01%	-2.82%	-18.17%	-19.32%	41.67B
BEONE MEDICINES AG	-3.73%	-6.04%	+28.41%	+22.76%	32.6B
REVOLUTION MEDICINES, INC.	-2.55%	+2.71%	+268.39%	+468.32%	30.97B
IQVIA HOLDINGS INC.	-0.91%	-5.37%	+18.41%	-11.55%	28.23B
CELLTRION, INC.	-3.23%	-4.84%	+27.92%	+22.28%	26.41B
ASCENDIS PHARMA A/S	-2.03%	+0.77%	-	-	14.94B
REGENCELL BIOSCIENCE HOLDINGS LIMITED	+6.21%	-2.39%	+176.35%	+4,385.95%	14.13B
IONIS PHARMACEUTICALS, INC.	-1.92%	-1.95%	+121.19%	+106.25%	12.27B
EUROFINS SCIENTIFIC SE	-0.20%	-0.10%	+5.63%	-1.89%	12.12B
Average	-0.94%	-1.65%	+78.52%	+621.60%	21.94B
Weighted average by Cap.	-1.47%	-2.12%	+69.48%	+392.98%